Firsts Home

Equity & Derivatives Companies, sectors, M&A and the financial industry
Amylin shares rise after CEO comments in Reuters interview 03.17.2009 Shares of Amylin Pharmaceuticals, which is under fire from dissident shareholders, rose nearly 14 percent in the two days following a Reuters interview on March 17 with the company’s CEO in which he defended the company’s growth strategy and indicated it was listening to all shareholders as it pulls together its roster of board nominees. Analysts cited the CEO’s reassuring comments as the reason for the gain in the company’s shares. Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here	firsts across any industry Commodities & Energy Energy, metals, agricultural and environmental markets FX & Money Markets Macroeconomics, monetary policy, FX and money markets Politics & Risk Politics and political risk Equity & Derivatives Companies, sectors, M&A and the financial industry Fixed Income Sovereign and corporate debt, credit, and ratings firsts by region Americas View stories from this region Europe / Middle East / Africa View stories from this region Asia View stories from this region Emerging Markets View stories from this region

Equity & Derivatives

Companies, sectors, M&A and the financial industry

Amylin shares rise after CEO comments in Reuters interview

03.17.2009

Shares of Amylin Pharmaceuticals, which is under fire from dissident shareholders, rose nearly 14 percent in the two days following a Reuters interview on March 17 with the company’s CEO in which he defended the company’s growth strategy and indicated it was listening to all shareholders as it pulls together its roster of board nominees. Analysts cited the CEO’s reassuring comments as the reason for the gain in the company’s shares.

Reuters Firsts will need at least flash player 9 to give you the full experience. The latest Flash player can be downloaded here